Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

SKB discloses fibrinogen and vitronectin antagonists in patent literature

May 17, 1996

Fibrinogen antagonist from natrual source reported by Takeda

May 17, 1996

Argatroban enters phase III for HIT, HITTS

May 17, 1996

Active-site thrombin inhibitors reported by BMS

May 17, 1996

Teijin claims anticoagulant peptides

May 17, 1996

LY-329186 + aspirin effective in canine thrombosis model

May 10, 1996

Platelet antiaggregatory activity seen with Asahi's L-103

May 10, 1996

Taisho research into fibrinogen antagonists

May 10, 1996

Nippon Steel discloses anticoagulant, antithrombotic peptide

May 10, 1996

Reteplase multiple boluses claimed for thromboembolic conditions

May 3, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...